EC Number | Cloned (Comment) | Organism |
---|---|---|
4.2.1.75 | expression of the N-terminal His-tagged wild-type and mutant enzymes in Escherichia coli BL21(DE3) | Homo sapiens |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
4.2.1.75 | 5 mg/ml purified recombinant wild-type and selenomethionine-enzyme, sitting drop vapour diffusion method, 4°C, equal volumes of protein solution, containing 10 mM Tris-HCl, pH 7.5, 1 mM dithiothreitol, and reservoir solution, containing 20% 2-methyl-2,4-pentanediol, 100 mM MES, pH 6.0, X-ray diffraction structure determination and analysis at 1.85-2.1 A resolution | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
4.2.1.75 | A66V | clinical mutation, altered tertiary structure | Homo sapiens |
4.2.1.75 | E127A | site-directed mutagenesis, unaltered activity level compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | E249stop | clinical mutation, truncated protein, loss of helix 12 | Homo sapiens |
4.2.1.75 | G225S | clinical mutation, altered tertiary structure | Homo sapiens |
4.2.1.75 | I129T | clinical mutation, altered tertiary structure | Homo sapiens |
4.2.1.75 | K220A | site-directed mutagenesis, slightly increased activity compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | L4F | clinical mutation, altered tertiary structure | Homo sapiens |
4.2.1.75 | additional information | the naturally occuring clinical mutations lead to loss in activity due to structural alterations in the enzymes, overview | Homo sapiens |
4.2.1.75 | P248Q | clinical mutation, altered tertiary structure | Homo sapiens |
4.2.1.75 | P53L | clinical mutation, altered tertiary structure | Homo sapiens |
4.2.1.75 | R65A | site-directed mutagenesis, slightly reduced activity compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | S197A | site-directed mutagenesis, unaltered activity level compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | S212P | clinical mutation, altered tertiary structure | Homo sapiens |
4.2.1.75 | S63A | site-directed mutagenesis, unaltered activity level compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | T103A | site-directed mutagenesis, reduced activity compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | T227A | site-directed mutagenesis, slightly increased activity compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | T228A | site-directed mutagenesis, conserved residue near to the active site cleft, reduced activity compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | T228M | clinical mutation, altered tertiary structure | Homo sapiens |
4.2.1.75 | T62A | site-directed mutagenesis, conserved residue near to the active site cleft, unaltered activity level compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | V3F | clinical mutation, altered tertiary structure | Homo sapiens |
4.2.1.75 | Y168A | site-directed mutagenesis, reduced activity compared to the wild-type enzyme | Homo sapiens |
4.2.1.75 | Y19C | clinical mutation, altered tertiary structure | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
4.2.1.75 | hydroxymethylbilane | Homo sapiens | linear tetrapyrrole, fourth step in the biosynthesis of porphyrin, essential reaction, decreased enzyme activity leads to the autosomal recessive disorder congenital erythropetic porphyria | uroporphyrinogen-III + H2O | macrocyclic uroporphyrinogen III is a precurosr for synthesis of diverse compounds, e.g. heme, siroheme, chlorophyll, F430, and vitamin B12 | ? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
4.2.1.75 | Homo sapiens | P10746 | - |
- |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
4.2.1.75 | hydroxymethylbilane = uroporphyrinogen III + H2O | in the presence of hydroxymethylbilane synthase EC 4.3.1.8, enzyme forms uroporphyrinogen III from porphobilinogen, reaction mechanism, does not require acid/base catalysis, active site structure | Homo sapiens |
EC Number | Renatured (Comment) | Organism |
---|---|---|
4.2.1.75 | recombinant His-tagged wild-type enzyme from Escherichia coli, to homogeneity | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
4.2.1.75 | hydroxymethylbilane | - |
Homo sapiens | uroporphyrinogen-III + H2O | - |
? | |
4.2.1.75 | hydroxymethylbilane | linear tetrapyrrole, fourth step in the biosynthesis of porphyrin, essential reaction, decreased enzyme activity leads to the autosomal recessive disorder congenital erythropetic porphyria | Homo sapiens | uroporphyrinogen-III + H2O | macrocyclic uroporphyrinogen III is a precurosr for synthesis of diverse compounds, e.g. heme, siroheme, chlorophyll, F430, and vitamin B12 | ? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
4.2.1.75 | More | observed interdomain flexibility might be important for catalysis, the active site is located between the domains | Homo sapiens |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
4.2.1.75 | U3S | - |
Homo sapiens |
4.2.1.75 | Uroporphyrinogen III synthase | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
4.2.1.75 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
4.2.1.75 | 8.2 | - |
assay at | Homo sapiens |